The Economist discusses this question:
But human kidneys are no ordinary commodity. Trading them is banned in most countries. So supply depends largely on the charity of individuals: some are willing to donate one of their healthy kidneys while they are still alive (at very little risk to their health); others agree to let their kidneys be used when they die. Unsurprisingly, with altruism the only incentive, not enough people offer.







![Urological analysis of delayed cancer diagnoses in political figures [PODCAST]](https://kevinmd.com/wp-content/uploads/Design-1-190x100.jpg)


![Racial disparities in pancreatic cancer screening cost Black lives [PODCAST]](https://kevinmd.com/wp-content/uploads/The-Podcast-by-KevinMD-WideScreen-3000-px-4-190x100.jpg)